The trajectory of Sildenafil presents a intricate picture for investors. While the initial launch generated significant profits, the end of its patent opened the door to generic alternatives, dramatically reducing https://kathrynflsy348016.ourcodeblog.com/42206860/sildenafil-and-the-pharmaceutical-industry-a-risky-bet